Consumption of fish oil supplement alters erythrocyte fatty acid composition in overweight, hypercholesterolemic, middle-aged Serbians

Nutrition Research

Volumn 27, Issue 9, 2007, Pages 529-534

  Duričić, Ivana ^a   Šobajić, Sladjana ^a   Peruničić Peković, Gordana ^b   Stojanov, Marina ^a   Rašić, Zorica ^b  

^a School of Pharmacy   (Yugoslavia)

^b University Hospital Zemun   (Serbia)

Author keywords

Erythrocytes; Fatty acid profile; Fish oil supplements; Humans; Hypercholesterolemia; Overweight

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ERYTHROCYTE; ERYTHROCYTE METABOLISM; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FEMALE; FISH; GAS CHROMATOGRAPHY; GROUPS BY AGE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; MALE; OBESITY; PRIORITY JOURNAL; YUGOSLAVIA;

EID: 34548293832     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.06.013     Document Type: Article

References (37)

1. Zamaria N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod Nutr Dev 44 1 (2004) 273-282
2. Ruxton C.H.S., Reed S.C., Simpson M.J.A., and Millington K.J. The health effect of omega-3 polyunsaturated fatty acids: a review of the evidence. Br Diet Assoc 17 1 (2004) 449-459
3. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune disease. Am J Clin Nutr 21 1 (2002) 495-505
4. von Schacky C., and Dyberg J. Omega-3 fatty acids. From Eskimos to clinical cardiology-what took us so long?. In: Hamazaki T., and Okuyama H. (Eds). Fatty acids and lipids-new findings (2001), Karger, Basel 90-99
5. Valentine R.C., and Valentine D.L. Omega-3 fatty acids in cellular membranes: a unified concept. Prog Lipid Res 43 1 (2004) 383-402
6. Bucher H.C., Hengstler P., Schindler C., and Meier G. n-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112 1 (2002) 298-304
7. Moyad M.A. An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part I. Urol Oncol 23 1 (2005) 28-35
8. Moyad M.A. An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part II. Urol Oncol 23 1 (2005) 36-48
9. Ransley J.K. The rise and rise of food and nutritional supplements-an overview of the market. In: Ransley J.K., Donnelly J.K., and Read N.W. (Eds). Food and nutritional supplements (2001), Springer, Berlin 1-16
10. Otto S.J., Foreman von Drongelen M.M., von Houwelingen A.C., and Homstra G. Effects of storage on venous and capillary blood samples: the influence of deferoxamine and butylated hydroxytoluene on the fatty acid alterations in red blood cell phospholipids. Eur J Clin Chem Clin Biochem 35 1 (1997) 907-913
11. Kates M. Techniques in lipidology (1972), North-Holland Publishing Company, Amsterdam
12. International standard ISO 5509-1978 (E).
13. International standard ISO 5508-1978 (E).
14. European pharmacopoeia. 4th ed. (2002), Council of Europe, Strasbourg
15. Bland M. An introduction to medical statistics. 3rd ed. (2000), Oxfor University Press, Oxford 211-216
16. www.edustat.info.
17. Greger J.L. Dietary supplement use: consumer characteristics and interests. J Nutr 131 (2001) 1339S-1343S
18. Satia-Abouta J., Kristal A.R., Patterson R.E., Littman A.J., Stratton K.L., and White E. Dietary supplement use and medical conditions-the VITAL study. Am J Prev Med 24 1 (2003) 43-51
19. Health condition, health needs, and health care in Republic Serbia. J Public Health Inst (Belgrade) 76 1 (2002) 23-149
20. Health condition, health needs, and health care of adult population in North Backa Region. J Public Health Inst (Belgrade) 73 1 (1999) 18-23
21. Scientific Review Committee. Nutrition recommendations (1990), Minister of National Health and Welfare, Canada, Ottawa
22. Department of Health. Nutritional aspects of cardiovascular diseases. Report on health and social subjects 46 (1994), HM Stationery Office, London
23. Scientific Advisory Committee on Nutrition (SACN). Advice on fish consumption: benefits and risks (2004), FSA, London
24. ISSFAL policy statement. www.issfal.org.uk.
25. Prisco D., Filippini M., Francalanci I., Paniccia R., Gensini G.F., Abbate R., et al. Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes. Am J Clin Nutr 63 1 (1996) 925-932
26. Yaqoob P., Pala H.S., Cortina-Borja M., Newsholme E.A., and Calder P.C. Encapsulated fish oil enriched in alfa-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 30 1 (2000) 260-274
27. Liu M., Wallin R., and Saldeen T. Effect of bread containing stable fish oil on plasma phospholipid fatty acids, triglycerides, HDL-cholesterol, and malondialdehyde in subjects with hyperlipidaemia. Nutr Res 21 1 (2001) 1403-1410
28. Higgins S., Carroll Y.L., O'Brien N.M., and Morrissey P.A. Use of microencapsulated fish oil as a means of increasing n-3 polyunsaturated fatty acid intake. J Hum Nutr Diet 12 (1999) 265-271
29. Gleize B., Payet M., Esmail M.H., Pieroni G., and Coste T.C. Docosahexaenoic acid-enriched egg phospholipids supplementation induces accretion of arachidonic acid in rat blood lipids. Cell Mol Biol 50 1 (2004) 861-867
30. Simopoulos A.P. Essential fatty acids in health and chronic disease. Am J Clin Nutr 70 3 Suppl (1999) 560S-569S
31. Lundberg W.O. The significance of cis, cis, cis 5,8,11, eicosatrienoic acid in essential fatty acid deficiency. Nutr Rev 38 1 (1980) 233-235
32. Siguel E.N., and Lerman R.H. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 1 1 (1996) 12-23
33. Serbian Republic Statistic Office, Report on household budget survey, 2000-2005.
34. Takahata K., Monobe K., Tada M., and Weber P.C. The benefits and risks of n-3 polyunsaturated fatty acids. Biosci Biotechnol Biochem 62 1 (1998) 2079-2085
35. Berstad P., Seljeflot I., Veierod M.B., Hjerkinn E.M., Arnesen H., and Pedersen J.I. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin Sci 105 1 (2003) 13-20
36. Theobald H.E., Chowienczyk P.J., Whittall R., Humphries S.E., and Sanders T.A.B. LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am J Clin Nutr 79 1 (2004) 558-563
37. Mabile L., Piolot A., Boulet L., Fortin L.J., Doyle N., Rodriguez C., et al. Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am J Clin Nutr 74 (2001) 449-456